Neurobiology of depression: Findings, controversies and perspectives

Neuropsychiatry

Volumn 1, Issue 3, 2011, Pages 199-202

  Minkwitz, Juliane ^a   Himmerich, Hubertus ^b  

^a Bariatric Surgery   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); AGOMELATINE; ANTIDEPRESSANT AGENT; CATECHOLAMINE; DOPAMINE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; SEROTONIN TRANSPORTER; TIANEPTINE; VASCULOTROPIN;

CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 16; CHROMOSOME 18; CHROMOSOME 20; CHROMOSOME 21; CHROMOSOME 22; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 9; DEPRESSION; DNA POLYMORPHISM; EPIGENETICS; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MOOD DISORDER; NEUROANATOMY; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY; PRIORITY JOURNAL; REVIEW; X CHROMOSOME;

EID: 84867705875     PISSN: 17582008     EISSN: 17582016     Source Type: Journal    
DOI: 10.2217/npy.11.25     Document Type: Review

References (19)

1. Maier W, Schwab S, Rietschel M: Genetik affektiver Störungen. In: Psychiatrie der Gegenwart 5, Schizophrene und Affektive Störungen (4th Edition). Helmchen H, Henn F, Lauter H, Sartorius N (Eds). Springer, Berlin/Heidelberg, Germany/New York, NY, USA, 373-407 (2000).
2. López-León S, Janssens AC, González-Zuloeta Ladd AM et al.: Meta-analyses of genetic studies on major depressive disorder. Mol. Psychiatry 13, 772-785 (2008). (Pubitemid 352032108)
3. Shyn SI, Shi J, Kraft JB et al.: Novel loci for major depression identified by genome-wide association study of sequenced treatment alternatives to relieve depression and meta-analysis of three studies. Mol. Psychiatry 16, 202-215 (2011).
4. Caspi A, Sugden K, Moffitt TE et al.: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301(5631), 386-389 (2003). (Pubitemid 36877077)
5. Mehta D, Menke A, Binder EB: Gene expression studies in major depression. Curr. Psychiatry Rep. 12, 135-144 (2010).
6. Schroeder M, Krebs MO, Bleich S, Frieling H: Epigenetics and depression: current challenges and new therapeutic options. Curr. Opin. Psychiatry 23, 588-592 (2010).
7. Drevets WC: Neuroimaging studies of mood disorders. Biol. Psychiatry 48, 813-829 (2000).
8. Genze E, Vermetten E, Brenner JD: MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol. Psychiatry 10, 160-184 (2005). (Pubitemid 40188512)
9. Fuchs E, Flügge G: Depressionen: eine störung der neuroplastizität? Psychoneuro 31, 197-203 (2005).
10. Sheline YI, Gado MH, Kraemer HC: Untreated depression and hippocampal volume loss. Am. J. Psychiatry 160, 1516-1518 (2003). (Pubitemid 41070930)
11. Schildkraut JJ: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 122, 509-522 (1965).
12. West CH, Ritchie JC, Boss-Williams KA, Weiss JM: Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons. Int. J. Neuropsychopharmacol. 12, 627-641 (2009).
13. Nickel T, Sonntag A, Schill J et al.: Clinical and neurobiological effects of tianeptine and paroxetine in major depression. J. Clin. Psychopharmacol. 23, 155-168 (2003). (Pubitemid 36368793)
14. Komossa K, Depping AM, Gaudchau A, Kissling W, Leucht S: Second-generation antipsychotics for major depressive disorder and dysthymia. Cochrane Database Syst. Rev. 12, CD008121 (2010).
15. Holsboer F, Ising M: Stress hormone regulation: biological role and translation into therapy. Annu. Rev. Psychol. 61, 81-109 (2010).
16. Schmider J, Lammers C-H, Gotthardt U, Dettling M, Holsboer F, Heuser IJ: Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I. Biol. Psychiatry 38, 797-802 (1995). (Pubitemid 3020006)
17. Himmerich H, Berthold-Losleben M, Pollmächer T: Die Bedeutung des TNF-a-Systems für Erkrankungen des gehirns. Fortschr. Neurol. Psychiatr. 77, 334-345 (2009).
18. Himmerich H, Fulda S, Sheldrick AJ, Plümäkers B, Rink L: IFN-g reduction by tricyclic antidepressants. Int. J. Psychiatry Med. 40, 413-424 (2010).
19. Himmerich H, Milenoví S, Fulda S et al.: Regulatory T cells increased while IL-1b decreased during antidepressant therapy. J. Psychiatr. Res. 44, 1052-1057 (2010).